Keywords: alteon, hypertension, drug, fails, achieve, main, goal

Alteon's hypertension drug fails to achieve main goal in Phase IIb trials

Article | 28 July 2003

Print This

USA-based Alteon has released disappointing preliminary results from two Phase IIb trials evaluating the use of ALT-711 in the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in